The Australian: AdAlta, SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapyLikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk AdAlta a question about this update.Discover